Forums before death by AOL, social media and spammers... "We can't have nice things"
|    sci.med.psychobiology    |    Dialog and news in psychiatry and psycho    |    4,734 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 3,451 of 4,734    |
|    =?UTF-8?B?4oqZ77y/4oqZ?= to All    |
|    Olfactory dysfunction predicts early tra    |
|    22 Feb 15 09:54:44    |
      From: hounddog23x@gmail.com              Article              Olfactory dysfunction predicts early transition to a Lewy body disease in       idiopathic RBD                      Authors       Abstract              Objective: The aim of the present study was to determine the predictive value       of olfactory dysfunction for the early development of a synuclein-mediated       neurodegenerative disease in subjects with idiopathic REM sleep behavior       disorder (iRBD) over an        observational period of 5 years.       Methods: Thirty-four patients with polysomnography-confirmed iRBD underwent       olfactory testing using the entire Sniffin' Sticks test assessing odor       identification, odor discrimination, and olfactory threshold. Patients with       iRBD were prospectively        followed up over a period of 4.9 ± 0.3 years (mean ± SD). The diagnosis of       neurodegenerative diseases was based on current clinical diagnostic criteria.       Results: After 2.4 ± 1.7 years (mean ± SD), 9 patients (26.5%) with iRBD       developed a Lewy body disease (6 Parkinson disease and 3 dementia with Lewy       bodies). The entire Sniffin' Sticks test and the identification subtest had       the same overall diagnostic        accuracy of 82.4% (95% confidence interval: 66.1%-92.0%) in predicting       conversion. The relative risk for a Lewy body disease in the lowest tertile of       olfactory function was 7.3 (95% confidence interval: 1.8-29.6) compared with       the top 2 tertiles.       Conclusions: Assessment of olfactory function, particularly odor       identification, may help to predict the development of a Lewy body disease in       patients with iRBD over a relatively short time period and thus to identify       patients suitable for future        disease modification trials.       Received June 30, 2014.       Accepted in final form October 24, 2014.       (c) 2015 American Academy of Neurology       Published online before print January 21, 2015, doi: 10.1212/WNL       0000000000001265 Neurology 10.1212/WNL.0000000000001265                                          http://m.neurology.org/content/early/2015/01/21/WNL.0000000000001265.abstract              --- SoupGate-Win32 v1.05        * Origin: you cannot sedate... all the things you hate (1:229/2)    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca